John David Finley insider trades

Open-market stock purchases and sales by John David Finley, CEO, CFO at Palisade BIO, Inc, from SEC Form 4 filings since Apr 27, 2021.

Track record: 56% of 9 scored buys are up 5% or more since purchase, averaging +85%.

Recent trades

DateStockTradeValue
Feb 12, 2026PALI Palisade BIO, IncSold$6.8K
Feb 11, 2026PALI Palisade BIO, IncBought (not open market)—
Feb 9, 2026PALI Palisade BIO, IncBought (not open market)—
Oct 6, 2025PALI Palisade BIO, IncBought (not open market)—

Companies traded

  • PALI Palisade BIO, Inc: 12 buys, 1 sale, last Feb 12, 2026

Get free alerts when John David Finley files a new trade →